SOTROVIMAB vs SPARSENTAN: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
SOTROVIMAB vs SPARSENTAN: Safety Overview
| Metric | SOTROVIMAB | SPARSENTAN |
|---|---|---|
| Total FAERS Reports | 4,117 | 3,280 |
| Deaths Reported | 187 | 18 |
| Death Rate | 4.5% | 0.5% |
| Hospitalizations | 488 | 209 |
| Average Patient Age | 59.7 yrs | 49.3 yrs |
| % Female Patients | 53.9% | 43.8% |
| FDA Approval Date | N/A | Feb 17, 2023 |
| Manufacturer | N/A | Travere Therapeutics, Inc. |
| Route | N/A | ORAL |
| Marketing Status | N/A | Prescription |